摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-丙基哌啶 | 3238-60-6

中文名称
2-丙基哌啶
中文别名
毒芹鹼
英文名称
rac-coniine
英文别名
2-propylpiperidine;Coniine
2-丙基哌啶化学式
CAS
3238-60-6
化学式
C8H17N
mdl
MFCD00056022
分子量
127.23
InChiKey
NDNUANOUGZGEPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    -2℃
  • 沸点:
    56-60 °C(Press: 13 Torr)
  • 密度:
    0.85 g/mL at 25 °C(lit.)
  • 物理描述:
    Liquid
  • 颜色/状态:
    COLORLESS LIQUID
  • 气味:
    MOUSY ODOR
  • 溶解度:
    SOLUBLE IN ALCOHOL, ETHER, ACETONE, BENZENE, AMYL ALCOHOL; SLIGHTLY SOL IN CHLOROFORM; ONE ML DISSOLVES IN 90 ML WATER, LESS SOL IN HOT WATER; THE BASE DISSOLVES ABOUT 25% WATER AT ROOM TEMPERATURE
  • 折光率:
    INDEX OF REFRACTION: 1.4505 @ 23 °C/D; SPECIFIC OPTICAL ROTATION: +16 DEG @ 19 °C/D
  • 解离常数:
    PK 3.1; K 7.5X10-4
  • 保留指数:
    992

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

ADMET

毒理性
  • 毒性总结
(S)-2-丙基哌啶是一种神经毒素,能够破坏周围神经系统。它对人类和所有类别的家畜都有毒性;对人类来说,不到0.2克就是致命的,死亡原因是呼吸麻痹。丙基哌啶首先刺激然后抑制自主神经节,具有类似尼古丁的作用,并且具有类似筒箭毒碱的效果,能够麻痹到骨骼肌的运动神经末梢。
(S)-2-Propylpiperidine is a neurotoxin which disrupts the peripheral nervous system. It is toxic to humans and all classes of livestock; less than 0.2g is fatal to humans, with death caused by respiratory paralysis. Propylpiperidine has a nicotine-like action in first stimulating and then depressing autonomic ganglia, and a curare-like effect in paralysing the motor nerve endings to the skeletal muscles.
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌物分类
对人类无致癌性(未列入国际癌症研究机构IARC清单)。
No indication of carcinogenicity to humans (not listed by IARC).
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 健康影响
外围神经系统破坏;呼吸麻痹;死亡。
Disruption of the peripheral nervous system; respiratory paralysis; death.
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 副作用
神经毒素 - 其他中枢神经系统神经毒素
Neurotoxin - Other CNS neurotoxin
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
毒理性
  • 人类毒性摘录
死亡发生迅速(少于3小时),最突出的体征和症状与外周麻痹和感觉丧失有关。症状包括嗜睡、感觉异常、无力、共济失调、恶心、大量流涎和心动过缓随后是心动过速。死亡是由于呼吸肌麻痹导致的呼吸停止,尽管在服用大剂量后中枢抑制可能发挥作用。
DEATH OCCURS RAPIDLY (LESS THAN 3 HR) WITH THE MOST PROMINENT SIGNS AND SYMPTOMS REFERABLE TO PERIPHERAL PARALYSIS AND LOSS OF SENSATION. SYMPTOMS INCLUDE DROWSINESS, PARESTHESIAS, WEAKNESS, ATAXIA, NAUSEA, PROFUSE SALIVATION AND BRADYCARDIA FOLLOWED BY TACHYCARDIA. DEATH IS DUE TO RESPIRATORY ARREST FROM PARALYSIS OF RESPIRATORY MUSCLES, ALTHOUGH CENTRAL DEPRESSION MAY PLAY A ROLE AFTER VERY LARGE DOSES.
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    T
  • 安全说明:
    S22,S36/37/39,S45
  • 危险类别码:
    R23/24/25,R40
  • WGK Germany:
    3
  • 海关编码:
    2933399090
  • 危险品运输编号:
    UN 2810
  • 储存条件:
    | 2-8°C |

SDS

SDS:3a70ba223f29bd41bd55e6b5d77d581b
查看

制备方法与用途

(±)- Coniine 是一种哌啶类生物碱,源自毒芹,具有生物活性。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Engineering an Enantioselective Amine Oxidase for the Synthesis of Pharmaceutical Building Blocks and Alkaloid Natural Products
    作者:Diego Ghislieri、Anthony P. Green、Marta Pontini、Simon C. Willies、Ian Rowles、Annika Frank、Gideon Grogan、Nicholas J. Turner
    DOI:10.1021/ja4051235
    日期:2013.7.24
    catalytic methods for the production of enantiomerically pure chiral amines is a key challenge facing the pharmaceutical and fine chemical industries. This challenge is highlighted by the estimate that 40-45% of drug candidates contain a chiral amine, fueling a demand for broadly applicable synthetic methods that deliver target structures in high yield and enantiomeric excess. Herein we describe the development
    开发用于生产对映异构纯手性胺的经济高效且可持续的催化方法是制药和精细化工行业面临的关键挑战。据估计,40-45% 的候选药物含有手性胺,这突显了这一挑战,这推动了对以高产率和对映体过量提供目标结构的广泛适用的合成方法的需求。在此,我们描述了来自黑曲霉 (MAO-N) 的单胺氧化酶变体“工具箱”的开发和应用,该变体显示出显着的底物范围和对空间要求基序的耐受性,包括一个新变体,它对含有以下物质的底物表现出高活性和对映选择性氨基二苯甲烷(二苯甲基胺)模板。通过将合理的结构导向工程与高通量筛选相结合,可以扩大 MAO-N 的底物范围以适应含有大量芳基取代基的胺底物。这些工程化的 MAO-N 生物催化剂已应用于去消旋反应,用于高效不对称合成仿制药活性药物成分索利那新和左西替利嗪以及天然产物 (R)-coniine、(R)-eleagnine 和 (R)-leptaflorine . 我们还报告了一种新的
  • Syntheses and Neuraminidase Inhibitory Activity of Multisubstituted Cyclopentane Amide Derivatives
    作者:Pooran Chand、Y. Sudhakar Babu、Shanta Bantia、Scott Rowland、Ali Dehghani、Pravin L. Kotian、Tracy L. Hutchison、Shoukath Ali、Wayne Brouillette、Yahya El-Kattan、Tsu-Hsing Lin
    DOI:10.1021/jm0303406
    日期:2004.4.1
    position 3, were tested for their ability to inhibit A and B forms of influenza neuraminidase. The 1-ethylpropylamide, diethylamide, dipropylamide, and 4-morpholinylamide showed very good inhibitory activity (IC(50) = 0.015-0.080 microM) vs the neuraminidase A form, but modest activity (IC(50) = 3.0-9.2 microM) vs the neuraminidase B form. Since the parent amides bear two chiral centers (C-1 and C-1'), three
    在旨在鉴定有效和安全的流感神经氨酸酶抑制剂的进一步研究中,我们合成了一系列多取代的环戊烷酰胺衍生物。所制备的酰胺是伯胺的14个实例的N-取代烷基或芳烷基,仲胺的13个实例的N,N-二取代的烷基,芳烷基或取代烷基,以及脂环族或取代的脂环族仲胺的12个实例。这些化合物具有两个手性中心,分别位于环的位置1和位置3的侧链的位置1',并具有抑制甲型和乙型流感神经氨酸酶的能力。与神经氨酸酶A形式相比,1-乙基丙基酰胺,二乙基酰胺,二丙基酰胺和4-吗啉基酰胺显示出非常好的抑制活性(IC(50)= 0.015-0.080 microM),但相对于神经氨酸酶B形式,活性适中(IC(50)= 3.0-9.2 microM)。由于母体酰胺带有两个手性中心(C-1和C-1'),因此以较高的非对映异构体纯度测试了三种较好的抑制剂。与1-(乙基)丙基酰胺,二乙基酰胺和二丙基酰胺的活性形式相对应的非对映异构体(在C-1
  • BENZIMIDAZOLE AND IMADAZOPYRIDINE CARBOXIMIDAMIDE COMPOUNDS
    申请人:Gilead Sciences, Inc.
    公开号:US20160333009A1
    公开(公告)日:2016-11-17
    The present disclosure provides indoleamine 2,3-dioxygenase 1 (IDOL) inhibitors of Formula I: or pharmaceutically acceptable salts thereof, in which X, L, n, m, R 1 , R 2a , R 2b , R n , R m , and R t are as defined herein, as well as pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using the same to treat conditions mediated by IDO1.
    本公开提供了式I的吲哌酮2,3-二氧化酶1(IDOL)抑制剂: 或其药学上可接受的盐,其中X、L、n、m、R 1 、R 2a 、R 2b 、R n 、R m 和R t 如本文所定义,以及包括式I化合物的药物组合物,或其药学上可接受的盐,并使用这些方法来治疗由IDO1介导的疾病。
  • Structure, Activity and Stereoselectivity of NADPH-Dependent Oxidoreductases Catalysing the<i>S</i>-Selective Reduction of the Imine Substrate 2-Methylpyrroline
    作者:Henry Man、Elizabeth Wells、Shahed Hussain、Friedemann Leipold、Sam Hart、Johan P. Turkenburg、Nicholas J. Turner、Gideon Grogan
    DOI:10.1002/cbic.201402625
    日期:2015.5.4
    production of chiral amines: The structures of imine reductases (IREDs) from B. cereus and N. halophila that are S‐selective for the reduction of 2‐methylpyrroline (2MPN) reveal conservation of residues in this IRED subgroup. These structures permit comparison with those of IREDs that are R‐selective for 2MPN reduction, revealing structural differences in the active sites.
    不对称产生手性胺的生物催化剂:蜡状芽孢杆菌和嗜盐生芽孢杆菌的亚胺还原酶(IRED)结构具有S选择性,可还原2-甲基吡咯啉(2MPN),显示该IRED亚组中的残基得以保留。这些结构可以与对2MPN还原具有R选择性的IRED进行比较,从而揭示了活性位点的结构差异。
  • Kinetic resolution of amines with enantiopure 3-N,N-diacylaminoquinazolin-4(3H)-ones
    作者:Al-Sehemi, Abdullah G.、Atkinson, Robert S.、Fawcett, John
    DOI:10.1039/b105917n
    日期:2002.1.7
    The title compounds (DAQs) are chiral when the two N-acyl groups are different because of the absence of rotation around the N–N bond (a chiral axis). Enantiopure DAQs have been obtained by incorporation of a chiral centre in enantiopure form either into the substituent at the Q2-position or into one of the N-acyl groups, or into both, followed by separation of diastereoisomers. This separation is unnecessary in one case because conversion of the N-monoacylaminoquinazolinone (MAQ) into the DAQ is completely diastereoselective. Neither is separation of diastereoisomers necessary with 3-[N,N-di-(S)-2-acetoxypropanoylamino]-2-diphenylmethylquinazolin-4(3H)-one 37a: this DAQ 37a has its N–N bond rendered a chiral axis by the bias in its imide moiety wholly in favour of one exo/endo conformation.The high chemoselectivity exhibited by N,N-diacetyl- or N,N-dibenzoylaminoquinazolinones in reaction with the less hindered of two secondary amines (pyrrolidine in the presence of 1 eq. of piperidine) has a stereoselective counterpart: reaction of the above enantiopure DAQs enantioselectively with racemic amines leading to kinetic resolution. Using 1 eq. of DAQ and 2 eq. of amine, both the derivatised and unreacted amine enantiomers are recovered with high enantiomeric excess (ee) (better than 90% ee in some cases). Some of the higher ees are found in the recovered amides where non-chemoselective attack on both N-acyl groups of the DAQ has occurred: from the opposite configurations of the amine component in the two amides and from the low enantiopurity of the recovered unreacted amine, reaction of each of the N-acyl groups with complementary enantiomers of the amine is occurring (parallel kinetic resolution).Although higher ees are, in general, obtained using secondary amines, high ees are obtained in some cases using 1-phenylethylamine and, in particular, amino acid esters (valine and alanine).The sense of enantioselectivity in the reactions of these DAQs with amines is controlled by the configuration of the N–N axis: replacing the Q group in an N-(S)-2-acetoxypropanoyl-N-acetyl-bearing DAQ by phthalimide, thus eliminating the N–N chiral axis, drastically reduces the level of kinetic resolution.
    标题化合物(DAQs)在两个N-酰基团不同时是手性的,因为N-N键(一个手性轴)缺乏旋转。通过将手性中心以手性形式引入Q2-位点的取代基或其中一个N-酰基团,或两者中,随后分离diastereoisomers,得到了纯对映体的DAQs。在一个情况下,这种分离是不必要的,因为将N-单酰胺基喹唑啉酮(MAQ)转化为DAQ是完全立体选择性的。对于3-[N,N-di-(S)-2-乙酰氧基丙酰胺基]-2-二苯甲基喹唑啉-4(3H)-酮37a,也不需要分离diastereoisomers:这个DAQ 37a通过其亚胺部分的偏向完全倾向于一个exo/endo构象,使其N-N键成为一个手性轴。N,N-二乙酰基或N,N-二苯甲酰氨基喹唑啉酮在与两个次级胺中较少受到阻碍的胺(在存在1 eq.的哌啶的情况下使用吡咯烷)反应时表现出高度的化学选择性,这在立体选择性上有对应:上述纯对映体的DAQs与外消旋胺反应,导致动力学拆分。使用1 eq.的DAQ和2 eq.的胺,衍生化的和未反应的胺对映体都以高对映体过量(ee)回收(在一些情况下优于90% ee)。在一些回收的酰胺中发现较高的ee,其中非化学选择性地攻击DAQ的两个N-酰基团:从两个酰胺中胺组分的相反构型和回收的未反应胺的低对映纯度,每个N-酰基团与胺的互补对映体反应(并行动态拆分)。尽管通常使用次级胺得到较高的ee,但在某些情况下使用1-苯乙胺,特别是氨基酸酯(缬氨酸和丙氨酸)得到高ee。这些DAQs与胺反应的对映选择性的方向受N-N轴配置的控制:在带有N-(S)-2-乙酰氧基丙酰基-N-乙酰基的DAQ中,通过用邻苯二甲酰亚胺替换Q组,从而消除N-N手性轴,显著降低了动力学拆分的水平。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台